VCL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.928400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.781820E-01
Normal-vs-Stage2
8.822200E-01
Normal-vs-Stage3
7.258800E-01
Normal-vs-Stage4
6.229200E-01
Stage1-vs-Stage2
1.139010E-01
Stage1-vs-Stage3
4.236200E-01
Stage1-vs-Stage4
4.865600E-02
Stage2-vs-Stage3
6.721600E-01
Stage2-vs-Stage4
3.330800E-01
Stage3-vs-Stage4
3.873800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.456000E-01
Normal-vs-AfricanAmerican
7.251400E-01
Normal-vs-Asian
9.738200E-01
Caucasian-vs-AfricanAmerican
8.694400E-01
Caucasian-vs-Asian
4.980400E-01
AfricanAmerican-vs-Asian
6.204800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.497200E-01
Normal-vs-Female
8.570600E-01
Male-vs-Female
5.027200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.870200E-01
Normal-vs-Age(41-60Yrs)
8.466200E-01
Normal-vs-Age(61-80Yrs)
6.909800E-01
Normal-vs-Age(81-100Yrs)
2.641400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.666400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.680600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.916000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.657900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.677300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.579400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.049800E-01
Normal-vs-Daily Drinker
3.430600E-01
Normal-vs-Weekly Drinker
7.320600E-01
Normal-vs-Occasional Drinker
7.947400E-01
Normal-vs-Social Drinker
9.767000E-01
Non Drinker-vs-Daily Drinker
4.497600E-01
Non Drinker-vs-Weekly Drinker
1.065230E-01
Non Drinker-vs-Occasional Drinker
5.371400E-01
Non Drinker-vs-Social Drinker
3.247600E-01
Daily Drinker-vs-Weekly Drinker
2.673900E-02
Daily Drinker-vs-Occasional Drinker
1.702010E-01
Daily Drinker-vs-Social Drinker
1.167970E-01
Weekly Drinker-vs-Occasional Drinker
2.770800E-01
Weekly Drinker-vs-Social Drinker
6.161200E-01
Occasional Drinker-vs-Social Drinker
6.504600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.809000E-01
Normal-vs-Grade 2
2.097700E-02
Normal-vs-Grade 3
6.100200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.837500E-03
Grade 1-vs-Grade 3
1.805820E-02
Grade 1-vs-Grade 4
3.809000E-01
Grade 2-vs-Grade 3
3.789400E-01
Grade 2-vs-Grade 4
2.097700E-02
Grade 3-vs-Grade 4
6.100200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.580000E-01
Normal-vs-NonDiabetic
8.565200E-01
Diabetic-vs-NonDiabetic
2.009200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.697800E-01
Normal-vs-NoPancreatitis
7.732200E-01
Pancreatitis-vs-NoPancreatitis
7.533800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.812600E-01
Normal-vs-N1
8.518000E-01
N0-vs-N1
3.370800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.510400E-01
Normal-vs-TP53-NonMutant
3.779800E-01
TP53-Mutant-vs-TP53-NonMutant
3.402300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
